Regions West | San Francisco
Aug 22, 2008
The Alexandria Center for Science and Technology at Mission Bay, a behemoth 2.7 million-square-foot life science cluster being developed by Alexandria Real Estate Equities Inc. in San Francisco, will become home to a division of Pfizer now that the pharmaceutical company has pre-leased 100,000 square feet at the property. Pfizer will operate its Biotherapeutics and Bioinnovation Center in the building at 455 Mission Bay Blvd. on the development's north campus. The company's long-term lease also allows for the potential expansion of its space by an additional 50,000 square feet. Upon completion, Alexandria Center will encompass 13 state-of-the-art facilities designed to accommodate the specific needs of life sciences companies. Other entities that have already committed to the office/laboratory development include the University of California San Francisco's orthopedic clinic and research and translational unit.
The Alexandria Center for Science and Technology at Mission Bay, a behemoth 2.7 million-square-foot life science cluster being developed by Alexandria Real Estate Equities Inc. in San Francisco, will become home to a division of Pfizer now that the pharmaceutical company has pre-leased 100,000 square feet at the property. Pfizer will operate its Biotherapeutics and Bioinnovation Center in the building at 455 Mission Bay Blvd. on the development's north campus. The company's long-term lease also allows for the potential expansion of its space by an additional 50,000 square feet. Upon completion, Alexandria Center will encompass 13 state-of-the-art facilities designed to accommodate the specific needs of life sciences companies. Other entities that have already committed to the office/laboratory development include the University of California San Francisco's orthopedic clinic and research and translational unit.
Recent San Francisco Headlines
Dec. 23, 2008
Dec. 09, 2008